SAGE Therapeutics (SAGE) – Analyst Ratings
-
Goldman Sachs Downgrades Sage Therapeutics (SAGE) to Neutral, 'stepping to the sidelines as we await more clarity'
-
Needham & Company Downgrades Sage Therapeutics (SAGE) to Hold
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SAGE Stock Lookup